Literature DB >> 9422927

Diagnostic value of fundus examination in familial adenomatous polyposis.

A Tiret1, M Taiel-Sartral, E Tiret, L Laroche.   

Abstract

BACKGROUND: Multiple, bilateral lesions of congenital hypertrophy of the retinal pigment epithelium (CHRPE) have been described in patients suffering from familial adenomatous polyposis (FAP) since 1980. This study aimed to determine a reliable diagnostic criterion, based on the size and number of retinal CHRPE lesions, allowing the screening of patient carriers of the gene responsible for FAP.
METHODS: 32 control subjects and 144 patients belonging to 85 FAP families were studied, divided into 124 carriers of the genetic alteration and 20 non-carriers.
RESULTS: In carriers of the deleted gene, multiple, bilateral retinal lesions were consistently observed. Lesion situation, size, shape, and degree of pigmentation were variable however. A positive criterion for FAP was defined as the presence of at least four lesions whatever their size, or at least two lesions one of which is large. This criterion showed a high sensitivity (0.68) and a maximal specificity (1). Within each family, the retinal phenotypic expression was homogeneous. CHRPE lesions were observed in two thirds of the FAP families and absent from the remaining third.
CONCLUSION: By using this new positive diagnostic criterion, fundus examination allows early detection of those children carrying the gene responsible for FAP in families positive at ocular examination.

Entities:  

Mesh:

Year:  1997        PMID: 9422927      PMCID: PMC1722327          DOI: 10.1136/bjo.81.9.755

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  42 in total

1.  Incidence and significance of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial adenomatous polyposis coli (FAPC).

Authors:  A T Moore; E R Maher; D J Koch; S J Charles
Journal:  Ophthalmic Paediatr Genet       Date:  1992-06

2.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.

Authors:  A Romania; Z N Zakov; E McGannon; T Schroeder; F Heyen; D G Jagelman
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

4.  The Gardner syndrome. Significance of ocular features.

Authors:  R A Lewis; W E Crowder; L A Eierman; R L Nussbaum; R E Ferrell
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

5.  A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome).

Authors:  E I Traboulsi; S F Murphy; Z C de la Cruz; I H Maumenee; W R Green
Journal:  Am J Ophthalmol       Date:  1990-11-15       Impact factor: 5.258

6.  Congenital hypertrophy of the retinal pigment epithelium predicts colorectal polyposis in Gardner's syndrome.

Authors:  E I Traboulsi; I H Maumenee; A J Krush; D Alcorn; F M Giardiello; R W Burt; J P Hughes; S R Hamilton
Journal:  Arch Ophthalmol       Date:  1990-04

7.  Importance of retinal pigmentation as a subclinical marker in familial adenomatous polyposis.

Authors:  S Baba; M Tsuchiya; I Watanabe; H Machida
Journal:  Dis Colon Rectum       Date:  1990-08       Impact factor: 4.585

8.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

9.  Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

Authors:  S Olschwang; A Tiret; P Laurent-Puig; M Muleris; R Parc; G Thomas
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis.

Authors:  R H Baker; M H Heinemann; H H Miller; J J DeCosse
Journal:  Am J Med Genet       Date:  1988-10
View more
  5 in total

1.  Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.

Authors:  Caitlin E Lawson; Thomas M Attard; Hongying Dai; Seth Septer
Journal:  J Genet Couns       Date:  2016-12-03       Impact factor: 2.537

2.  Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Authors:  Rosario Touriño; Rogelio Conde-Freire; José M Cabezas-Agrícola; Teresa Rodríguez-Aves; Maria Jesús López-Valladares; José L Otero-Cepeda; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

3.  Gardner's syndrome: genetic testing and colonoscopy are indicated in adolescents and young adults with cranial osteomas: a case report.

Authors:  Dubravko Smud; Goran Augustin; Tihomir Kekez; Emil Kinda; Mate Majerovic; Zeljko Jelincic
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

4.  Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran

Authors:  Seyed Kazem Mirinezhad; Farideh Mousavi; Masood Baghri; Bita Sepehri; Ali Ghavidel; Morteza Ghojazadeh; Mohammad Hossein Somi
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

Review 5.  Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Authors:  Louis Antoine Bonnet; R Max Conway; Li-Anne Lim
Journal:  Clin Ophthalmol       Date:  2022-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.